ResiStent
Congenital heart disease (CHD) is the most common birth defect in the United States, occurring in 1 out of every 100 babies. In most cases, babies born with CHD must undergo a risky procedure with a 47% reintervention rate in which a modified adult coronary stent is implanted into the ductus arteriosus, an artery that closes shortly after birth. Starlight Cardiovascular is attempting to solve this problem by developing a self-expanding stent tailored specifically to the ductus arteriosus.